Vaccination can
Help Protect
someone you care for
against COVID-19
The vaccines may not protect everyone.
Explore vaccine options by Pfizer and BioNTech.
Choose an age group to learn more.
INDICATION
COMIRNATY® (COVID‑19 Vaccine, mRNA) is a vaccine approved for active immunization to prevent coronavirus disease 2019 (COVID‑19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula)†
Ages 6 Months Through 11 Years
†EMERGENCY USE AUTHORIZATION
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 6 months through 11 years of age. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.
New Update
The U.S. Food & Drug Administration (FDA) has issued an emergency use authorization and approval for COVID-19 vaccines by Pfizer and BioNTech.
The FDA has issued full approval for COMIRNATY® (COVID-19 Vaccine, mRNA), designed for the XBB variant, for individuals 12 years of age and older and has updated the emergency use for Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) for all doses administered to people 6 months through 11 years of age.
Find a vaccine
appointment near you.
Pfizer is working closely with Pharmacies, hospitals and clinics across the country to ensure rapid access to this season’s vaccines.
Check back later for updates.
Most people should continue to pay $0 out-of-pocket for COVID-19 vaccines.
Uninsured or underinsured? Please read the below information.